Terkko Navigator / Hematology/ Feeds

A novel dual inhibitor of microtubule and Bruton's Tyrosine Kinase inhibits survival of multiple myeloma and osteoclastogenesis.

A retrospective analysis of the application of the Elecsys® HIV combi PT assay in southern China

Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population

Evaluation of the URiSCAN 2 ACR Strip to estimate the urine albumin/creatinine ratios

NaOH–HCl neutralized urine preparation for direct testing of uropathogens by Bruker MS

Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.

Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.

Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.

ASH President Expresses Disappointment with Senate Health Care Bill

ASH President Applauds Introduction of Patients’ Access to Treatment Act

New Antibody Uses One-Two Punch to Potentially Treat Blood Cancers

ASH to Develop Clinical Guidelines to Improve Care for People with Sickle Cell Disease

American Society of Hematology Selects 22 Underrepresented Medical Students for Minority Medical Student Award Program

Transplant Community & Sickle Cell Disease Advocates Urge Congress to Advance Policies Supporting Sickle Cell Disease Research and Treatment

Precision Therapy Enasidenib Effective in Treating Deadly Form of Leukemia

ASH President Responds to President Trump’s Proposal to Cut One in Five Dollars to NIH, Public Health Programs

The American Society of Hematology Selects Catherine Zander, PhD, for the New ASH Congressional Fellowship Program

American Society of Hematology Announces 2017-2018 Physician-Scientist Career Development Award Recipients

ASH President Responds to House Passage of American Health Care Act

Join ASH at the March for Science!

Medical Groups Unite in Support of Science

ASH Awards $750k to Preserve Promising Biomedical Research

Hematology Fellows and Junior Faculty Participate in 2017 ASH Clinical Research Training Institute in Latin America

Anticoagulant Apixaban Superior to Warfarin for Reducing Brain Bleeds in Patients with Atrial Fibrillation

Statement from ASH President on Administration’s Proposed Cuts to NIH

Statement From ASH President on Administration's Revised Executive Order on Immigration

Statement from ASH President on Introduction of the Cancer Drug Parity Act

American Society of Hematology Announces 2017 Translational Research Training in Hematology Program Participants

Specialty Physician Groups Publish Guideline to Improve Care for Acute Leukemia Patients

Study: Children, Parents Over-Report Leukemia Treatment Adherence

Statement from ASH, AACR, AACI, ASTRO, ASPHO, and LUNGevity Foundation on the Administration’s Executive Order on Immigration

ASH President Submits Letter to Secretary-Designate Tom Price on 2017 Health Care and Research Priorities

2017 ASH-AMFDP Scholars to Study Basic Insights in Blood Cancer Development

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

Prognostic relevance of oxidative stress measurement In chronic lymphocytic leukemia

Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism. Indirect comparison of clinical trials.

Efficacy of ezetimibe combined with atorvastatin in treatment of carotid artery plaque in patients with type 2 diabetes mellitus complicated with coronary heart disease.

Sickle Cells Produce Functional Immune Modulators and Cytotoxics

History of consolidation is prognostic in AML patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission

Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with Hyper-CVAD based regimens

Elevated solubleα-hemoglobin pool in Sickle Cell Anemia

The Sickle [beta]-Thalassemia Phenotype.

Health-related Quality of Life and its Predictors Among Transfusion-dependent Thalassemia Patients.

T2* Magnetic Resonance Imaging Study of Pancreatic Iron Overload and its Relation With the Diabetic State in Thalassemic Patients.

Invasive Pneumococcal Disease in Patients With Sickle Cell Disease.

Clinic Attendance of Youth With Sickle Cell Disease on Hydroxyurea Treatment.

Attention Deficit Hyperactivity Disorder in Children With Sickle Cell Disease Referred for an Evaluation.

Multimorbidity and Genetic Characteristics of DICER1 Syndrome Based on Systematic Review.

Assessing National Cancer Control Plan Knowledge, Prioritization, and Engagement Through a Pediatric Oncology Cancer Control Workshop.

Appendicitis in a Neutropenic Patient: A Multicentric Retrospective Study.